Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

KORU Medical Systems (KRMD) Enterprise Value (2020 - 2025)

KORU Medical Systems (KRMD) has disclosed Enterprise Value for 11 consecutive years, with -$8.5 million as the latest value for Q3 2025.

  • On a quarterly basis, Enterprise Value rose 3.89% to -$8.5 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$8.5 million, a 3.89% increase, with the full-year FY2024 number at -$9.6 million, up 16.56% from a year prior.
  • Enterprise Value was -$8.5 million for Q3 2025 at KORU Medical Systems, down from -$8.1 million in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of -$8.1 million in Q2 2025 to a low of -$26.8 million in Q1 2021.
  • A 5-year average of -$15.3 million and a median of -$11.7 million in 2023 define the central range for Enterprise Value.
  • Peak YoY movement for Enterprise Value: tumbled 260.47% in 2021, then soared 45.85% in 2023.
  • KORU Medical Systems' Enterprise Value stood at -$25.3 million in 2021, then soared by 31.29% to -$17.4 million in 2022, then skyrocketed by 34.04% to -$11.5 million in 2023, then grew by 16.56% to -$9.6 million in 2024, then rose by 11.66% to -$8.5 million in 2025.
  • Per Business Quant, the three most recent readings for KRMD's Enterprise Value are -$8.5 million (Q3 2025), -$8.1 million (Q2 2025), and -$8.7 million (Q1 2025).